Uncategorized - March 17, 2021
Results of whole genome sequencing project
The integration of large-scale genomics into the Stockholm region’s healthcare system has helped 1,200 people with rare diseases receive diagnosis. A study from Karolinska Institutet has analyzed the result of the first five years of collaboration on whole genome sequencing between Karolinska University Hospital and SciLifeLab. The work, published in Genome Medicine, constitutes a major […]
COVID-19 - February 23, 2021
The SciLifeLab program on COVID-19 vaccine effects is launched
In December 2020, SciLifeLab and the Knut and Alice Wallenberg Foundation (KAW), announced a call for a national program studying the effects of COVID-19 vaccines. 24 proposals were submitted and now, the program is launched, with 10 projects approved for funding, according to a press release from SciLifeLab. “In both the situation we are in […]
COVID-19 - February 16, 2021
A majority retained protective antibodies 9 months after infection, shows new study
As many as 96 percent of those infected with COVID-19 retain protective antibodies for at least nine months after confirmed infection. This is shown by a study from Danderyd Hospital and Karolinska Institutet using antibody tests developed by researchers at KTH and the SciLifeLab Autoimmunity Profiling facility, among them, Peter Nilsson (SciLifeLab/KTH). The COMMUNITY study […]
Collaboration - February 2, 2021
ESS, MAX IV and SciLifeLab join forces
Infra Access for Life Science Sweden (InfraLife) is a new life science initiative which aims to maximize the benefits of investments made in Sweden’s large-scale strategic research infrastructures. The aim with the joint effort is to seek synergies and expand the knowledge and availability of new technologies to new user groups to be able to […]
Clinical Trials - October 28, 2020
Kancera donates chemical library to SciLifeLab and initiates drug development collaboration
Kancera is donating a chemical library to the national research infrastructure, Chemical Biology Consortium Sweden (CBCS), at SciLifeLab, in order to support national drug development and the study of disease biology. A collaboration between Kancera and CBCS is also being initiated, which gives Kancera the opportunity to identify new drug candidates for future drug development. […]
COVID-19 - August 17, 2020
Medivir and SciLifeLab collaborate on potential SARS CoV-2 inhibitors
Medivir has entered a research collaboration with the Drug Discovery and Development Platform (DDD) at SciLifeLab on potential inhibitors of SARS CoV-2. Through the collaboration, DDD will get access to Medivir’s protease-targeted compound library, states the company in its press release. Data will be released on-line The aim of the collaboration is to find potential […]
